NorthStar Healthcare Income, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NHHS research report →
Price Chart
About the company
NorthStar Healthcare Income, Inc. (NHHS) concentrates its investment strategy on the healthcare real estate sector. The company's core mission involves acquiring, originating, and actively managing a broad range of equity, debt, and securities investments, either directly or through joint ventures.
- CEO
- Kendall K. Young
- IPO
- 2021
- Employees
- 8
- HQ
- New York City, NY, US
Get TickerSpark's AI analysis on NHHS
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $343.57M
- P/E
- 3.49
- PEG
- 0.00
- P/S
- 1.66
- P/B
- 1.49
- EV/EBITDA
- 15.93
- Div Yield
- 0.00%
- Gross Margin
- 99.65%
- Op Margin
- 9.55%
- Net Margin
- 47.42%
- ROE
- 53.84%
- ROIC
- 1.69%
Latest fiscal year · YoY change
- Revenue
- $206.66M+0.8%
- Gross Profit
- $205.93M+696.5%
- Op Income
- $19.74M
- Net Income
- $97.99M+162.5%
- EPS
- $0.53+163.9%
- OCF Growth
- +25.9%
- FCF Growth
- +141.4%
- 52W High
- $1.85
- 52W Low
- $0.00
- 50D MA
- $1.85
- 200D MA
- $1.50
- Beta
- -382.13
- RSI (14)
- 81
- Avg Volume
- 5.95K
No earnings-call transcripts are available for NHHS yet.
- Free Float
- 100.0%
- Shares Outstanding
- 185.71M
- Float Shares
- 185.71M
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 9, 25 | Samay Gregory A | sell | 147,801 |
| Jun 9, 25 | Smith Thomas Andrew | sell | 113,296 |
| Jun 9, 25 | Carnella Jonathan A. | sell | 111,251 |
| Oct 1, 23 | Harrington Ann | other | 0 |
| Jun 21, 23 | Smith Thomas Andrew | other | 29,010 |
| Jun 21, 23 | Samay Gregory A | other | 29,010 |
| Jun 21, 23 | Carnella Jonathan A. | other | 29,010 |
| Jun 21, 23 | Carnella Jonathan A. | other | 29,010 |
| Jun 21, 23 | Carnella Jonathan A. | other | 29,010 |
| Oct 21, 22 | Young Kendall K | other | 0 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our NHHS coverage
Recent articles, reports, and earnings notes.
No research on NHHS yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate NHHS report →